Erratum: Real-World Impact of Low-Grade Toxicities to Adjuvant Pembrolizumab in Stage III Melanoma A systematic search of EMBASE and MEDLINE was conducted from January 2000 to November 2024, following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results